1.Evaluation of the efficacy of milrinone in treatment of chronic congestive heart failure
Chinese Journal of Clinical Pharmacology and Therapeutics 2002;0(06):-
AIM: To estimate the efficacy of milrnone in treatment of congestive heart failure. METHODS: 122 cases of chronic congestive heart failure with different etiology were divided into milrinone group and dabutamine group randomly. Milrinone group accepted milrinone (10 mg?d -1 ) for 5 days, and dabutamine group accepted dabutamine (160 mg?d -1 ) for 5 days. The efficacy of treatments was evaluated. RESULTS: The effectiveness rates of cardiac function improvement were 93.9 % and 76.7 % in milrinone group and dabutamine group, respectively (P
2.Effect of resilience onself-care behaviors in chronic heart failure patients
Chinese Journal of Practical Nursing 2016;32(31):2414-2417
Objective To describe the status of resilience and self-care behaviors in chronic heart failure patients and to explore the relationship between resilience and self-care behaviors. Methods It was a cross-sectional survey. The Connor-Davidson Resilience Scale, the self-care behaviors with heart failure questionnaire and the demographic scale were delivered to 150 chronic heart failure patients in Shanghai Changhai Hospital. Results The score of self-care behaviors was (2.63 ± 2.01) points for chronic heart failure patients. The resilience score was (57.56 ± 8.51) points. The resilience was significantly related to the self-care behaviors(r=0.427, P<0.01), and which explained 32.4%of the total variation. Conclusions The chronic heart failure patients have poor self-care behaviors and resilience. More attention should be paid and more action be taken to improve the resilience, then improve the self-care behaviors of patients.
3.The clinical efficacy of anti-tuberculosis combined、with high-dose methylprednisolone in treatment of advanced tuberculous meningitis
Chinese Journal of Primary Medicine and Pharmacy 2011;18(11):1460-1461
Objective To observe the clinical efficacy and security of anti-tuberculosis combined with highdose methylprednisolone in treatment of advanced tuberculous meningitis.Methods 77 patients with advanced tuberculous meningitis in our department were randomly divided into the observation group(39 cases)and the control group (38 cases).All of the patients were given initiate antiphthisie treatment,the control group were added dexamethasone,20mg/d,iv drip,then was maintained after improved;the observation group were added high-dose methyprednisolone(500mg/d)by intravenous injection for five days,then was given methyprednisolone 80mg/d to maintain.Two groups were treated with hormone no more than three months.Then the clinical efficacy and adveme reaction were compared.Results The observation group:32 cases of healing,6 cases of effective,1 case of inefficient,the total effective rate was 97.4%and the control group were 22,8,8,78.9%;the difference of total effective rates in the two groups was statistically significant(x2=7.57,P<0.05).The time of consciousness restoration and defevesence,the white blood cell count,protein chloride and glucose content of cerebrospinal fluid of the observation group were(2.7±1.3)d,(13±5)d,(112.37±27.57)×106/L,(3.04±0.82)g/L,(32.7±6.4)mmol/L and(1.67±0.65)mmol/L;and the control group were(5.2±2.4)d,(19±6)d,(93.74±20.18)×106/L,(1.92±0.64)g/L,(25.4 ±5.2)mmol/L and(1.04±0.34)mmol/L,the difference was statistically significant(t=5.70,4.77,3.88,6.67,5.48,5.31,P<0.01);The difference of adverse reaction rate between the two groups was not statistically significant (P<0.05).Conclusion The clinical efficacy of anti-tuberculosis combined with high-dose methylprednisolone in treatment of advanced tuberculous meningitis was better and had advantages in improving symptoms and signs without enhancing the rate of adverse reaction and it was worth to promote in clinical.
5.Component Analysis of Chinese Patent Drugs Including Toxicity Components Used in Pediatrics
China Pharmacy 2007;0(31):-
OBJECTIVE: To analyze the situation and the related problems of Chinese patent drugs including toxicity components used in pediatrics, and to provide the suggestion for the development of Chinese patent drugs for pediatrics. METHODS: 264 Chinese patent drugs which were used in pediatrics were collected from national drug standards, and compared with toxicity drug list. The utilization of toxicity drugs were analyzed statistically. RESULTS: About half of Chinese patent drugs for pediatric included toxicity components. Major problems are complex resource of toxicity components, overdose of toxicity components, single disease and pattern, unscientific determination of amount, etc. CONCLUSION: The in-depth study of Chinese patent drugs requires perfecting national drug standards, to developing more rigorous special approval requirements, to establishing the re-evaluation system and to eliminating unsuitable category of Chinese patent drugs.
6.Teacher Ma Dazheng’s Experience in Treating Leukorrhagia
Journal of Zhejiang Chinese Medical University 2015;(12):864-866
Objective] To explore Ma Dazheng professor Chinese medicine treatment for the treatment of leukorrhagia. [Methods] Ma ’s treatment of gynecological disease discusses perspectives and clinical experience in terms of academic pathogenesis, treatment, therapies, their basic prescription compatibility and subtraction of the common CD features are summarized.[Results] Ma Dazheng professor applied lishi, tonifying spleen qi, kidney spleen, heat detoxification treatment, heat treatment and water as the main syndromes, pixu(spleen deficient), spleen kidney Yang deficiency type and the wet poison down, had clinical curative effect. [Conclusion] Ma Dazheng professor according to the characteristics of the patients in the process of treating leukorrhagia, syndrome differentiation and treatment, obtained the clinical accuracy and good curative effect, the gynecological clinical diagnosis and treatment had a good guiding significance, worthy of our in-depth study and understanding.
7.Studies on the Quality Control of Diedahuoxue Film
China Pharmacy 1991;0(02):-
OBJECTIVE:To establish a method for quality control of Diedahuoxue film METHODS:Indentification of the ingredients in the film was performed by TLC and the content of emodin in film was detected by spectrophotometry at wavelength of 512nm RESULTS:The average recovery was 101 2%,and RSD=0 78% CONCLUSION:This method is good in repeatability and can be used for quality control of the film
8.Determination of Hydroquinone in Compound Hydroquinone Cream by HPLC
China Pharmacy 1991;0(03):-
OBJECTIVE:To establish a HPLC method for the determination of hydroquinone in compound hydroquinone cream.METHODS:The assay was conducted on a Kromasil-C 18 column with methanol-water(30∶70)as mobile phase and the detection wavelength was293nm.RESULTS:The linear concentration range of hydroquinone was2.5~60?g/ml with the recovery of99.9%(RSD=0.73%).CONCLUSION:The method may be used for the determination of hydroquinone in cream.
9.Comparative study of heterogeneity of extranodal and nodal diffuse large B cell lymphoma
Journal of Peking University(Health Sciences) 2004;0(02):-
Objective:Primary nodal and extranodal diffuse large B-cell lymphoma(DLBCL)were investigated for the heterogeneity of histopathology and immunophenotype,and their relation to clinical stage,comparatively.Whether E2F1 can be used as a germinal center B cell(GCB)DLBCL marker was also discussed.Methods:Classification of histopathology and immunophenotype of 98 cases were studied by immunohistochemistry in tissue microarray.Results:Histopathologic morphology presented as:centroblastic(CB,88.8%,87/98),immunoblastic(IB,5.1%,5/98),anaplastic(ALCL,3.1%,3/98),and T cell rich B cell lymphoma(TCRBCL,3.1%,3/98).Of which,31 cases were GCB DLBCL,10(20.8%,10/48)nodal,and 21 extranodal(42%,21/50,P=0.024).The rates of Stages Ⅰ/Ⅱ in nodal and extranodal area were 48.5% and 70%,respectively(P=0.015).The rate of Stage Ⅰ/Ⅱ in GCB DLBCL(74.2%)were higher than in non-GCB DLBCL(50.7%,P=0.029).The CD10 positive rates were 36.8% and 17.1% in Stages Ⅰ/Ⅱ and Ⅲ/Ⅳ,respectively,and had significant differences(P=0.033).The CD10 positive rates were 18.8% and 38% in nodal and extranodal area,respectively(P=0.035).The positive rates of E2F1 were 38.8% and 16.5% in GCB and non-GCB DLBCL,respectively,and had significant differences(P=0.016).The positive rate of E2F1 had positive relation with the expression of CD10 and Bcl-6(P
10.Helicobacter pylori genotypes of gastrointestinal B cell lymphoma
Journal of Peking University(Health Sciences) 2004;0(02):-
Objective:To assess the expression of specific virulence-associated Helicobacter pylori (Hp) genotypes, (cag A, vac A, and ice A status) in primary gastrointestinal B cell lymphoma. Methods: Forty-nine paraffin wax embedded tissues were analyzed by immunohistochemical staining and poly-merase chain reaction. Results:There were 14 cases of mucosa associated lymphoid tissue lymphoma ( MALT-L) (8 in stomach, and 6 in intestine) and 35 cases of diffuse large B cell lymphoma (DLBCL) (21 in stomach, and 14 in intestine) in all. The positive rates of vac A s1 ,vac A s2 ,vac A m2,ice A 1 and cag A were 50. 0% ,42. 9% ,50. 0% , 14. 3% and 85. 7% in MALT-L; 57. 1% ,40. 0% ,25. 7% , 5.7% and91.4% in DLBCL, respectively. Conclusion:High toxicity cag A + Hp strains.seem to play a role in the pathogenesis of gastrointestinal B cell lymphoma, whereas vac A m2 may be more associated with MALT-L. Clinical stage was not associated with virulence-associated Hp genotypes.